(1) Giwercman A, Carlsen E, Keiding N, Skakkebæk NE. Evidence for increasing incidence of abnormalities of the human testis: a review. Environ Health Perspect Suppl 1993; 101:65-71.

(2) Sharpe RM, Skakkebæk NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993; 341:1392-1395.

(3) Nelson CMK, Bunge RG. Semen analysis: evidence for changing parameters of male fertility potential. Fertil Steril 1974; 25:503-507.

(4) Bostofte E, Serup J, Rebbe H. Has the fertility of Danish men declined through the years in terms of semen quality? A comparison of semen qualities between 1952 and 1972. Int J Fertil 1983; 28:91-95.

(5) James WH. Secular trend in reported sperm counts. Andrologia 1980; 12:381-388.

(6) Carlsen E, Giwercman A, Keiding N, Skakkebæk NE. Evidence for decreasing quality of semen during past 50 years. Br Med J 1992; 305:609-613.

(7) Tummon IS, Mortimer D. Decreasing quality of semen. Br Med J 1992; 305:1228-1229.

(8) Olsen GW, Bodner KM, Ramlow JM, Ross CE, Lipshultz LI. Have sperm counts been reduced 50 percent in 50 years? a statistical model revisited. Fertil Steril 1995; 63:887-893.

(9) Swan SH, Elkin EP, Fenster L. The question of declining sperm density revisited: an analysis of 101 studies published 1934-1996. Environ Health Perspect 2000; 108(10):961-966.

(10) Vierula M, Niemi M, Keiski A, Saaranen M, Saarikoski S, Suominen J. High and unchanged sperm counts of Finnish men. Int J Androl 1996; 19:11-17.

(11) Auger J, Kunstmann JM, Czyglik F, Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years [see comments]. N Engl J Med 1995; 332:281-285.

(12) Bujan L, Mansat A, Pontonnier F, Mieusset R. Time series analysis of sperm concentration in fertile men in Toulouse, France between 1977 and 1992. Br Med J 1996; 312:471-472.

(13) Irvine S, Cawood E, Richardson D, MacDonald E, Aitken J. Evidence of deteriorating semen quality in the United Kingdom: birth cohort study in 577 men in Scotland over 11 years. Br Med J 1996; 312:467-471.

(14) Van Waeleghem K, De Clercq N, Vermeulen L, Schoonjans F, Comhaire F. Deterioration of sperm quality in young healthy Belgian men. Hum Reprod 1996; 11:325-329.

(15) Fisch H, Goluboff ET, Olson JH, Feldshuh J, Broder SJ, Barad DH. Semen analyses in 1,283 men from the United States over a 25-year period: no decline in quality. Fertil Steril 1996; 65:1009-1014.

(16) Paulsen CA, Berman NG, Wang C. Data from men in greater Seattle area reveals no downward trend in semen quality: futher evidence that deterioration of semen quality is not geographically uniform. Fertil Steril 1996; 65:1015-1020.

(17) Gyllenborg J, Skakkebaek NE, Nielsen N-C, Keiding N, Giwercman A. Secular and seasonal changes in semen quality among young Danish men: a statistical analysis of semen samples from 1927 donor candidates during 1977-1995. Int J Androl 1999; 22:28-36.

(18) Handelsman DJ. Sperm output of healthy men in Australia: magnitude of bias due to self-selected volunteers. Hum Reprod 1997; 12:2701-2705.

(19) Bonde JPE, Ernst E, Jensen TK, Hjollund NHI, Kolstad H, Henriksen TB et al. Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet 1998; 352:1172-1177.

(20) Akre O, Cnattingius S, Bergstrom R, Kvist U, Trichopoulos D, Ekbom A. Human fertility does not decline: evidence from Sweden. Fertil Steril 1999; 71(6):1066-1069.

(21) Joffe M. Time trends in biological fertility in Britain. Lancet 2000; 355(9219):1961-1965.

(22) Adami H-O, Bergström R, Möhner M, Zatonski W, Storm H, Ekbom A et al. Testicular cancer in nine Northern European countries. Int J Cancer 1994; 59:33-38.

(23) Ekbom A, Akre O. Increasing incidence of testicular cancer-birth cohort effects. APMIS 1998; 106:225-231.

(24) Møller H. Decreased testicular cancer tisk in men born in wartime. J Natl Cancer Inst 1989; 81:1668-1669.

(25) Chilvers C, Pike MC, Forman D, Fogelman K, Wadsworth ME. Apparent doubling of frequency of undescended testis in England and Wales in 1962-81. Lancet 1984; 2:330-332.

(26) Matlai P, Beral V. Trends in congenital malformations of external genitalia. Lancet 1985; i:108.

(27) Czeizel A, Tóth J, Czvenits E. Increased birth prevalence of isolated hypospadias in Hungary. Acta Paediatr Hung 1986; 27:329-337.

(28) Kallen B, Winberg J. An epidemiological study of hypospadias in Sweden. Acta Paediatr Scand Suppl 1982; 293.

(29) Ansell PE, Bennett V, Bull D, Jackson MB, Pike LA, Pike MC et al. Cryptorchidism: a prospective study of 7500 consecutive male births, 1984-8. Arch Dis Child 1992; 67:892-899.

(30) Lahermo P, Sajantila A, Sistonen P, Lukka M, Aula P, Peltonen L et al. The genetic relationship between the Finns and the Finnish Saami (Lapps): analysis of nuclear DNA and mtDNA. Am J Hum Genet 1996; 58(6):1309-1322.

(31) WHO. Congenital Malformations Worldwide: A Report from The International Clearinghouse for Birth Defects Monitoring Systems. Oxford: Elsevier, 1991.

(32) Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJJr et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996; 104:741-803.

(33) Jensen TK, Slama R, Ducot B, Suominen J, Cawood EH, Andersen AG et al. Regional differences in waiting time to pregnancy among fertile couples from four European cities. Hum Reprod 2001; 16(12):2697-2704.

(34) Jørgensen N, Andersen AG, Eustache F, Irvine D, Suominen J, Petersen JH et al. Regional differences in semen quality in Europe. Hum Reprod 2001; 16:1012-1019.

(35) Jorgensen N, Carlsen E, Nermoen I, Punab M, Suominen J, Andersen AG et al. East-West gradient in semen quality in the Nordic-Baltic area: a study of men from the general population in Denmark, Norway, Estonia and Finland. Hum Reprod 2002; 17(8):2199-2208.

(36) Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, Schmidt IM et al. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 2004; 363(9417):1264-1269.

(37) Boisen KA, Chellakooty M, Schmidt IM, Kai CM, Damgaard IN, Suomi AM et al. Hypospadias in a cohort of 1072 Danish newborn boys: prevalence and relationship to placental weight, anthropometrical measurements at birth, and reproductive hormone levels at three months of age. J Clin Endocrinol Metab 2005; 90(7):4041-4046.

(38) Virtanen HE, Kaleva M, Haavisto AM, Schmidt IM, Chellakooty M, Main KM et al. The birth rate of hypospadias in the Turku area in Finland. APMIS 2001; 109(2):96-100.

(39) Richthoff J, Rylander L, Hagmar L, Malm J, Giwercman A. Higher sperm counts in Southern Sweden compared with Denmark. Hum Reprod 2002; 17:2468-2473.

(40) Auger J, Kunstmann JM, Czyglik F, Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med 1995; 332:281-285.

(41) Swan SH, Brazil C, Drobnis EZ, Liu F, Kruse RL, Hatch M et al. Geographic differences in semen quality of fertile U.S. males. Environ Health Perspect 2003; 111(4):414-420.

(42) Bonde JP, Ernst E, Jensen TK, Hjøllund H, Kolstad HA, Henriksen TB et al. Semen qulity and fertility in a population-based follow-up study. Ugesk Læger 1999; 161:6485-6489.

(43) Joffe M. Decreased fertility in Britain compared with Finland. Lancet 1996; 347:1519-1522.

(44) Andersen AG, Jensen TK, Carlsen E, Jørgensen N, Andersson A-M, Krarup T et al. High frequency of sub-optimal semen quality among young men of the general Danish population. Hum Reprod 2000; 15:366-372.

(45) Spano M, Bonde JP, Hjøllund H, Kolstad AH, Cordelli E, Leter G et al. Sperm chromatin damage impairs human fertility. Fertil Steril 1999; 73:1-9.

(46) Larson KI, DeJonge CJ, Barnes AM, Jost LK, Evenson DP. Sperm chromatin structure assay parameters as predictors of failed pregnancy following assisted reproductive techniques. Hum Reprod 2001; 15:1717-1722.

(47) Hernberg S. Lead poisoning in a historical perspective. Am J Ind Med 2000; 38:244-254.

(48) Gilfillan SC. Lead poisoning and the fall of Rome. J Occup Med 1965; 7:53-60.

(49) Gill WB, Schumacher GF, Bibbo M, Straus FH2, Schoenberg HW. Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J Urol 1979; 122:36-39.

(50) Wilcox AJ, Baird DD, Weinberg CR, Hornsby PP, Herbst AL. Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med 1995; 332:1411-1416.

(51) Gill WB, Schumacher GFB, Bibbo M. Genital and semen abnormalities in adults males two and one-half decades after in utero exposure to diethylstilbestrol. In: Herbst AL, editor. Intrauterine Exposure to Diethylstilbestrol in the Human. Chicago: American College of Obstetricians and Gynecologists, 1978: 53.

(52) Guo YL, Hsu PC, Hsu CC, Lambert GH. Semen quality after prenatal exposure to polychlorinated biphenyls and dibenzofurans. Lancet 2000; 356:1240-1241.

(53) Swan SH, Kruse RL, Liu F, Barr DB, Drobnis EZ, Redmon JB et al. Semen quality in relation to biomarkers of pesticide exposure. Environ Health Perspect 2003; 111(12):1478-1484.

(54) Richthoff J, Rylander L, Jönsson B, Åkesson H, Hagmar L, Nilsson-Ehle P et al. Serum levels of 2,2´,4,4´,5,5´-hexachlorobiphenyl (CB-153) in relation to markers of reproductive function in young males from the general Swedish population. Environ Health Perspect. In press.

(55) Toft G, Rignell-Hydbom A, Tyrkiel E, Shvets M, Giwercman A, Lindh CH et al. Semen quality and exposure to persistent organochlorine pollutants in an Inuit and three European cohorts. Epidemiology. In press.

(56) Giwercman A, Rylander L, Rignell-Hydbom A, Jonsson BA, Pedersen HS, Ludwicki JK et al. Androgen receptor gene CAG repeat length as a modifier of the association between persistent organohalogen pollutant exposure markers and semen characteristics. Pharmacogenet Genomics 2007; 17(6):391-401.

(57) Van Oostdam JC, Dewailly E, Gilman A, Hansen JC, Odland JO, Chashchin V et al. Circumpolar maternal blood contaminant survey, 1994-1997 organochlorine compounds. Sci Tot Environ 2004; 330:55-70.

(58) Lundin KB, Giwercman A, Dizeyi N, Giwercman YL. Functional in vitro characterisation of the androgen receptor GGN polymorphism. Mol Cell Endocrinol 2007; 264(1-2):184-187.

(59) Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, Calafat AM et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 2005; 113(8):1056-1061.

(60) Skakkebæk NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001; 16:972-978.

(61) Mocarelli P, Gerthoux PM, Ferrari E, Patterson Jr DG, Kieszak S, Brambilla P et al. Paternal concentration of dioxin and sex ratio of offspring. Lancet 2000; 355:1858-1863.

(62) Colborn T, Clement C. Chemically-induced alterations in sexual and functional development: the wildlife/human connection. Princeton: Princeton Scientific Publishing, 1992.

(63) Guillette LJJr, Gross TS, Masson GR, Matter JM, Percival HF, Woodward AR. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ Health Perspect 1994; 102:680-688.

(64) Guillette LJJr, Gross TS, Gross DA, Rooney AA, Percival HF. Gonadal steroidogenesis in vitro from juvenile alligators obtained from contaminated or control lakes. Environ Health Perspect 1995; 103 supplement 4:31-36.

(65) Clemens MJ. Regulation of egg protein synthesis by steroid hormones. Prog Biophysical Molecular Biology 1978; 28:71-108.

(66) Purdom CE, Hardiman PA, Bye VJ, Eno NC, Tyler CR, Sumpter JP. Estrogenic effects of effluents from sewage treatment works. Chemistry and Ecology 1994; 8:275-285.

(67) Jobling S, Sumpter JP. Detergent components in sewage effluent are weakly oestrogenic to fish: An in vitro study using rainbow trout (Oncorhynchus mykiss) hepatocytes. Aquatic Toxicol 1993; 27:361-372.

(68) Facemire CF, Gross TS, Guillette LJJr. Reproductive impairment in the Florida panther: nature or nurture. Environ Health Perspect 1995; 103 (Suppl. 4):(in press).

(69) Jensen TK, Henriksen TB, Scheike T, Hjollund NHI, Kolstad HA, Giwercman A et al. Adult and prenatal exposures to tobacco smoke as risk indicators of fertility among 430 Danish couples. Am J Epidemiol 1998; 148:992-997.

(70) Jensen TK, Hjollund NHI, Henriksen TB, Scheike T, Kolstad H, Giwercman A et al. Does moderate alcohol consumption affect fertility? Follow up study among couples planning first pregnancy. BMJ 1998; 317:505-510.

(71) Jensen TK, Giwercman A, Carlsen E, Scheike T, Skakkebæk NE. Semen quality among members of organic food associations in Zealand, Denmark. Lancet 1996; 347:1844.

(72) Dunphy BC, Barratt CLR, Cooke ID. Male alcohol consumption and fecundity in couples attending an infertility clinic. Andrologia 1991; 23:219-221.

(73) Storgaard L, Bonde JP, Ernst E, Spano M, Andersen CY, Frydenberg M et al. Does smoking during pregnancy affect sons' sperm counts? Epidemiology 2003; 14(3):278-286.

(74) Tiepolo L, Zuffardi O. Localization of factors controlling spermatogenesis in the nonfluorescent portion of the human Y chromosome long arm. Hum Genet 1976; 34(2):119-124.

(75) Hiort O, Holterhus P-M, Horter T, Schulze W, Kremke B, Bals-Pratsch M et al. Significance of mutations in the androgen receptor gene in males with idiopathic infertility. JCEM 2000; 85:2810-2815.

(76) Giwercman Y, Nikoshkov A, Byström B, Pousette Å, Arver S, Wedell A. A novel mutation (N233K) in the transactivating domain and the N756S mutation in the ligand binding domain of the androgen receptor gene are associated with male infertility. Clin Endocrinol 2001; 54:827-834.

(77) Quigley CA, De Bellis A, Marschke KB, El-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995; 16:271-321.

(78) Lubahn DB, Joseph DR, Sullivan P, Willard HF, French FS, Wilson EM. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 1988; 240:327-330.

(79) Brown TR, Lubahn DB, Wilson EM, Joseph DR, French FS, Migeon CJ. Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. Proc Natl Acad Sci USA 1988; 85:8151-8155.

(80) Giwercman A, Kledal TS, Schwartz M, Giwercman Y, Leffers H, Zazzi H et al. Preserved male fertility despite decreased androgen sensitivity caused by mutation in the ligand-binding domain of the androgen receptor gene. JCEM 2000; 85:2253-2259.

(81) Akin JW, Behzadian A, Tho SPT, McDonough PG. Evidence for a partial deletion in the androgen receptor gene in a phenotypic male with azoospermia. Am J Obstet Gynecol 1991; 165:1891-1894.

(82) Yong EL, Ng SC, Roy AC, Yun G, Ratnam SS. Pregnancy after hormonal correction of severe spermatogenic defect due to mutation in androgen receptor gene. Lancet 1994; 344:826-827.

(83) Sleddens HFBM, Oostra BA, Brinkmann AO, Trapman J. Trinucleotide repeat polymorphism in the androgen receptor gene. Nucleic Acids Res 1992; 20:1427.

(84) Chang C, Kokontis J, Liao S. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci USA 1988; 85:7211-7215.

(85) Lubahn DB, Joseph DR, Sar M, Tan J, Higgs HN, Larson RE et al. The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 1988; 2:1265-1275.

(86) Faber PW, Kuiper GGJM, van Rooij HCJ, van der Korput J, Brinkmann AO, Trapman J. The N-terminal domain of the human androgen receptor is encoded by one, large exon. Mol Cell Endocrinol 1989; 61:257-262.

(87) Kittles RA, Young D, Weinrich S, Hudson J, Argyropoulos G, Ukoli F et al. Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: implications for prostate cancer risk. Hum Genet 2001; 109:253-261.

(88) Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC, Feigelson H et al. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res 1998; 58:4497-4504.

(89) Edwards A, Chakraborty R, Jin L, Caskey CT. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 1992; 12:241-253.

(90) Giovannucci E. Is the androgen receptor CAG repeat length significant for prostate cancer? Cancer Epidemiology, Biomarkers & Prevention 2002; 11:985-986.

(91) Giwercman YL, Xu C, Arver S, Pousette Å, Reneland R, Lithell H et al. No association between the androgen receptor gene CAG repeat and impaired sperm production in Swedish men. Clin Genet 1998; 54:435-436.

(92) La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991; 352:77-79.

(93) La Spada AR, Roling DB, Harding AE, Warner CL, Spiegel R, Hausmanowa Petrusewicz I et al. Meiotic instability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet 1992; 2:301-304.

(94) Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L, Young EL. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production and male infertility. JCEM 1997; 82:3777-3782.

(95) Dowsing AT, Yong EL, Clark M, McLachlan RI, de Kretser DM, Trounson AO. Linkage between male infertility and trinucleotide repeat expansion in the androgen receptor gene. The Lancet 1999; 354:640-643.

(96) Legius E, Vanderschueren D, Spiessens C, D´Hooghe T, Matthijs G. Association between CAG repeat number in the androgen receptor and male infertility in a Belgian study. Clin Genet 1999; 56:166-167.

(97) Lundberg Giwercman Y, Xu C, Arver S, Pousette Å, Reneland R. No association between the androgen receptor gene CAG repeat and impaired sperm production in Swedish men. Clin Genet 1998; 54:435-436.

(98) Hiort O, Horter T, Schulze W, Kremke B, Sinnecker GH. Male infertility and increased risk of diseases in future generations. Lancet 1999; 354:1907-1908.

(99) Dadze S, Wieland C, Jakubiczka S, Funke K, Schroder E, Royer-Pokora B et al. The size of the CAG repeat in exon 1 of the androgen receptor gene shows no significant relationship to impaired spermatogenesis in an infertile Caucasoid sample of German origin. Mol Hum Reprod 2000; 6:207-214.

(100) Rajpert-De Meyts E, Leffers H, Petersen JH, Andersen A-G, Carlsen E, Jørgensen N et al. CAG repeat length in androgen receptor gene and reproductive variables in fertile and infertile men. Lancet 2002; 359:44-46.

(101) Komori S, Kasumi H, Kanazawa R, Sakata K, Nakata Y, Kato H et al. CAG repeat length in the androgen receptor gene of infertile Japanese males with oligozoospermia. Molecular Human Reproduction 1999; 5:14-16.

(102) Davis-Dao CA, Tuazon ED, Sokol RZ, Cortessis VK. Male infertility and variation in CAG repeat length in the androgen receptor gene: a meta-analysis. J Clin Endocrinol Metab 2007; 92:4319-4326.

(103) Aschim EL, Nordenskjold A, Giwercman A, Lundin KB, Ruhayel Y, Haugen TB et al. Linkage between Cryptorchidism, Hypospadias, and GGN Repeat Length in the Androgen Receptor Gene. J Clin Endocrinol Metab 2004; 89(10):5105-5109.

(104) Hillmer AM, Hanneken S, Ritzmann S, Becker T, Freudenberg J, Brockschmidt FF et al. Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet 2005; 77:140-148.

(105) Lundin KB, Giwercman YL, Rylander L, Hagmar L, Giwercman A. Androgen receptor gene GGN repeat length and reproductive characteristics in young Swedish men. Eur J Endocrinol 2006; 155:347-354.

(106) Lundin KB, Giwercman A, Dizeyi N, Giwercman YL. Functional in vitro characterisation of the androgen receptor GGN polymorphism. Mol Cell Endocrinol 2007; 264:184-187.